CHO Pharma, Inc. (TPEX: 6586)
Taiwan
· Delayed Price · Currency is TWD 52.20
-0.80 (-1.51%)
Nov 20, 2024, 11:11 AM CST
CHO Pharma Company Description
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs.
It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia.
The company was founded in 2012 and is based in Taipei City, Taiwan.
CHO Pharma, Inc.
| Country | Taiwan |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Chung-Yi Wu |
Contact Details
Address: Building C Taipei, 115202 Taiwan | |
| Phone | 886 2 2655 8059 |
| Website | chopharma.com |
Stock Details
| Ticker Symbol | 6586 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006586001 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Chung-Yi Wu Ph.D. | President, Chief Executive Officer, GM and Director |
| Sammi Chou | Chief Financial Officer |
| Dr. Ling-Mei Wang | Vice President of Operation |
| Yibei Zhou | Accounting Supervisor |